Claude

IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

IntuitionLabs

Veeva Study Startup: Survey Task screenshot

A detailed, source-attributed reference for the visible Study Startup interface, based on a public Veeva product image or demonstration capture.

Veeva Vault Study Startup Survey Task interface screenshot

What this Study Startup screenshot shows

This screenshot displays an email inbox interface illustrating the receipt of study startup notifications sent from Veeva Vault. The interface shows a filtered view of messages under the label "feas-outreach" with two specific emails listed. The first email, sent by Veeva Vault, announces that Verteo Biopharma is planning a Phase III study with Vertexo in patients with Non-small Cell Lung Cancer. The second email is a task reminder titled "Task Reminder: Complete Survey" dated August 29, 2021. This layout represents how external site personnel or investigators receive outreach and task assignments during the initial stages of clinical trial site feasibility. The view includes standard email navigation, search filters such as unread status, and basic account storage information at the bottom, demonstrating the integration of system-generated notifications within a standard user inbox.

Visible interface elements

  • Search bar containing the query label:feas-outreach
  • Active filter button labeled Is unread highlighted in blue
  • Email from Veeva Vault with subject line regarding a Phase III study by Verteo Biopharma
  • Email from Veeva Vault with subject line Task Reminder: Complete Survey dated 8/29/21
  • Action icons for archiving, deleting, and snoozing on the highlighted email row
  • Storage indicator at the bottom left showing 0% of 15 GB used
  • Last account activity timestamp indicating 5 hours ago

Interface details

The interface presents a standard webmail inbox layout with a search bar at the top containing the query "label:feas-outreach". Below the search bar, several filter dropdowns are visible, including "From", "Any time", "Has attachment", and "To", alongside an active blue button for "Is unread" and an "Advanced search" link. The main content area lists two email threads from the sender "Veeva Vault". The top thread features a bold subject line regarding a Phase III study by Verteo Biopharma for Non-small Cell Lung Cancer, marked with a yellow importance indicator. The second thread is a task reminder for completing a survey, dated August 29, 2021. Action icons such as archive, delete, mark as unread, and snooze appear on the right side of the highlighted email row. The top right of the screen contains standard utility icons for help, settings, and application switching. The bottom of the page displays storage usage showing "0% of 15 GB used" and a timestamp indicating the last account activity occurred five hours ago.

Workflow context

In the context of clinical trial operations, this interface demonstrates how automated notifications from Veeva Vault Study Startup reach external stakeholders, such as potential clinical investigators or site coordinators. The visible emails represent critical touchpoints in the site feasibility and selection workflow. By receiving direct email notifications, such as the initial study announcement and the subsequent task reminder to complete a survey, site personnel are alerted to pending actions without needing to remain constantly logged into the sponsor portal. This mechanism can support timely communication and could help accelerate the site qualification process by keeping feasibility tasks visible within the user's primary daily workspace. Clinical operations teams can utilize these system-generated outreach emails to track response rates and manage follow-ups, helping to ensure that critical-path milestones in the study startup phase are met efficiently.

Source, version, and interpretation limits

The screenshot is sourced from an official Veeva hosted demo for Veeva Study Startup Feasibility Surveys, published around 2020. It depicts a simulated site-facing email inbox receiving automated notifications. Because this is a static image of a third-party email client interface, it does not confirm real-time delivery, active integration, or the automated validation of survey responses within Veeva Vault. The displayed data, including the sponsor name Verteo Biopharma and the specific Phase III lung cancer study, represents synthetic demonstration data. Actual user interfaces, email templates, and specific configurations may vary depending on the organization's setup, system version, and regional settings.

Authoritative references

Use these primary sources to confirm current product positioning, terminology, and release-specific behavior.

Product: Veeva Vault ClinicalCategory: Study StartupCataloged: 7/30/2026

© 2026 IntuitionLabs. All rights reserved.